Figure 4
![Figure 4. Inhibition of tumor relapse by adoptive transfer of allogeneic anti–third-party Tcm. Lethally irradiated (8Gy TBI) BALB/c (H-2d) mice received an intravenous transplant of 3 × 106 allogeneic TDBM cells (B6 nude [H-2b]) in the presence or absence of 5 × 103A20-luc lymphoma cells (day 0). Mice were then (day +1) intravenously injected with 5 × 106 B6-derived anti–third-party Tcm (A20+ Allo Tcm; n = 7) or left untreated (A20 only; n = 8). (A) Tumor growth was monitored by BLI from day 13 at weekly intervals. (B) Survival rates of the animals in the different treatment groups are shown.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/121/15/10.1182_blood-2012-06-432443/4/3033f4.jpeg?Expires=1735534655&Signature=E8velnbIHxE9VggCwRXIUaIw32FeLZ~DUMjaLuoyrsTesqUxflEY-U12V67uhTRQmhv5E0TJoAU3h021x~Cilu2ENXqhNkat~IsJ5p8nbO1xaFguLAyO9ptDYOKO8clkfFqpDVKj8gK8SI9MM8PFFuwbk4wXC8VQTe47bYGWChvL~wBtLnPAT8GsCwHV~6Cf7HJwMeAAoDIVm8rCoRDyhi60l8dBtsmo-z1ZwmAgm0JTIr791kXvwlaZ7TyK4isnBcyo7BZj638KGtxwBvsI6K9qx6mL8FLcLb~H3wBvtYiNjtYjcpsb9MIMIvEbJIQaV3g018vk23-zNWnmjyKCUg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Inhibition of tumor relapse by adoptive transfer of allogeneic anti–third-party Tcm. Lethally irradiated (8Gy TBI) BALB/c (H-2d) mice received an intravenous transplant of 3 × 106 allogeneic TDBM cells (B6 nude [H-2b]) in the presence or absence of 5 × 103A20-luc lymphoma cells (day 0). Mice were then (day +1) intravenously injected with 5 × 106 B6-derived anti–third-party Tcm (A20+ Allo Tcm; n = 7) or left untreated (A20 only; n = 8). (A) Tumor growth was monitored by BLI from day 13 at weekly intervals. (B) Survival rates of the animals in the different treatment groups are shown.
